Full Text View
Tabular View
No Study Results Posted
Related Studies
Phase I Study of Isotretinoin in Patients With Recessive Dystrophic Epidermolysis Bullosa
This study is ongoing, but not recruiting participants.
Study NCT00014729   Information provided by FDA Office of Orphan Products Development
First Received: April 10, 2001   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Epidermolysis Bullosa
Additional conditions recognized in this trial
Epidermolysis Bullosa Dystrophica
More general conditions related to this trial
Collagen Diseases
Congenital Abnormalities
Connective Tissue Diseases
Genetic Diseases, Inborn
Skin Abnormalities
Skin Diseases
Skin Diseases, Genetic
Skin Diseases, Vesiculobullous
Interventions listed in this trial
isotretinoin
More general drug interventions related to this trial
Dermatologic Agents
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
FDA Office of Orphan Products Development
University of North Carolina


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services